Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
d-MPH on Quality of Life in Brain Tumor Patients Receiving Radiation Therapy
NCT00031798Phase 3Terminated
- Sponsor
- Wake Forest University Health Sciences
- Start
- Apr 2002
- Primary completion
- Mar 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dexmethylphenidate in fatigue, major depressive disorder (MDD), cognitive impairment, sponsored by Wake Forest University Health Sciences. Started Apr 2002; status: terminated.
02
Drugs
dexmethylphenidate
03
Conditions
fatiguemajor depressive disorder (MDD)cognitive impairment
Beyond the preview
Go deeper on NCT00031798.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00031798.